201 related articles for article (PubMed ID: 8157675)
21. The carboxy terminal 110 amino acid portion of the insulin receptor is important for insulin signalling to pyruvate dehydrogenase.
Gottschalk WK; Lammers R; Ullrich A
Biochem Biophys Res Commun; 1992 Dec; 189(2):906-11. PubMed ID: 1472063
[TBL] [Abstract][Full Text] [Related]
22. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes.
Modan-Moses D; Janicot M; McLenithan JC; Lane MD; Casella SJ
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):825-31. PubMed ID: 9677346
[TBL] [Abstract][Full Text] [Related]
24. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors.
Schumacher R; Mosthaf L; Schlessinger J; Brandenburg D; Ullrich A
J Biol Chem; 1991 Oct; 266(29):19288-95. PubMed ID: 1655782
[TBL] [Abstract][Full Text] [Related]
25. Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.
Sprynski AC; Hose D; Kassambara A; Vincent L; Jourdan M; Rossi JF; Goldschmidt H; Klein B
Leukemia; 2010 Nov; 24(11):1940-50. PubMed ID: 20844560
[TBL] [Abstract][Full Text] [Related]
26. Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1).
Galvan V; Logvinova A; Sperandio S; Ichijo H; Bredesen DE
J Biol Chem; 2003 Apr; 278(15):13325-32. PubMed ID: 12556535
[TBL] [Abstract][Full Text] [Related]
27. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes.
Park BC; Kido Y; Accili D
Biochemistry; 1999 Jun; 38(23):7517-23. PubMed ID: 10360949
[TBL] [Abstract][Full Text] [Related]
28. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
29. Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors.
Lamothe B; Baudry A; Christoffersen CT; De Meyts P; Jami J; Bucchini D; Joshi RL
FEBS Lett; 1998 Apr; 426(3):381-5. PubMed ID: 9600271
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors.
Langlois WJ; Sasaoka T; Yip CC; Olefsky JM
Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646
[TBL] [Abstract][Full Text] [Related]
31. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
[TBL] [Abstract][Full Text] [Related]
32. N-linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling.
Leconte I; Auzan C; Debant A; Rossi B; Clauser E
J Biol Chem; 1992 Aug; 267(24):17415-23. PubMed ID: 1324936
[TBL] [Abstract][Full Text] [Related]
33. The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.
Abbas A; Imrie H; Viswambharan H; Sukumar P; Rajwani A; Cubbon RM; Gage M; Smith J; Galloway S; Yuldeshava N; Kahn M; Xuan S; Grant PJ; Channon KM; Beech DJ; Wheatcroft SB; Kearney MT
Diabetes; 2011 Aug; 60(8):2169-78. PubMed ID: 21677284
[TBL] [Abstract][Full Text] [Related]
34. RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth.
Zhang W; Zong CS; Hermanto U; Lopez-Bergami P; Ronai Z; Wang LH
Mol Cell Biol; 2006 Jan; 26(2):413-24. PubMed ID: 16382134
[TBL] [Abstract][Full Text] [Related]
35. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
36. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
Chen H; Yan GC; Gishizky ML
Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
[TBL] [Abstract][Full Text] [Related]
37. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells.
Baudry A; Lamothe B; Bucchini D; Jami J; Montarras D; Pinset C; Joshi RL
FEBS Lett; 2001 Jan; 488(3):174-8. PubMed ID: 11163767
[TBL] [Abstract][Full Text] [Related]
38. The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts.
Takata Y; Imamura T; Haruta T; Sasaoka T; Morioka H; Ishihara H; Sawa T; Usui I; Ishiki M; Kobayashi M
Metabolism; 1996 Dec; 45(12):1474-82. PubMed ID: 8969279
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing.
Da Silva Xavier G; Qian Q; Cullen PJ; Rutter GA
Biochem J; 2004 Jan; 377(Pt 1):149-58. PubMed ID: 14563207
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-1 activation of extracellular signal-related kinase-1 and -2 in growth hormone-secreting cells.
Webster J; Prager D; Melmed S
Mol Endocrinol; 1994 May; 8(5):539-44. PubMed ID: 8058064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
